AQST vs JNJ: Which Stock is Better?
Side-by-side comparison of Aquestive Therapeutics Inc and Johnson & Johnson in 2026
AQST
Aquestive Therapeutics Inc
—
JNJ
Johnson & Johnson
$232.77
Key Metrics Comparison
| Metric | AQST | JNJ | Winner |
|---|---|---|---|
| Market Cap | $493.02M | $375.37B | JNJ |
| P/E Ratio | N/A | 17.35 | JNJ |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze AQST
Full quant analysis
Analyze JNJ
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is AQST or JNJ a better investment?
Comparing AQST and JNJ: Aquestive Therapeutics Inc has a market cap of $493.02M while Johnson & Johnson has $375.37B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between AQST and JNJ?
AQST (Aquestive Therapeutics Inc) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: AQST or JNJ?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: AQST or JNJ?
Both AQST and JNJ show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: AQST or JNJ?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: AQST or JNJ?
Johnson & Johnson (JNJ) is larger with a market cap of $375.37B compared to $493.02M for AQST.
Should I buy AQST or JNJ in 2026?
Both AQST and JNJ have investment merit. AQST trades at $N/A while JNJ trades at $232.77. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between AQST and JNJ stock?
Key differences: Market Cap ($493.02M vs $375.37B), P/E Ratio (N/A vs 17.4x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy AQST or JNJ in 2026?
The choice between AQST and JNJ depends on your investment goals. JNJ shows higher revenue growth (0.0%). JNJ has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between AQST and JNJ?
AQST (Aquestive Therapeutics Inc) has a market cap of $493.02M, while JNJ (Johnson & Johnson) has a market cap of $375.37B. JNJ is the larger company by market value.